<DOC>
	<DOCNO>NCT01860963</DOCNO>
	<brief_summary>This study design establish prevalence anal squamous intraepithelial lesion ( ASIL ) patient inflammatory bowel disease ( IBD ) healthy control .</brief_summary>
	<brief_title>Anal Dysplasia Patients With Inflammatory Bowel Disease Healthy Controls</brief_title>
	<detailed_description>IBD patient attend Stanford Inflammatory Bowel Disease ( IBD ) clinic age-matched healthy control screen eligibility . Informed consent obtain eligible subject . An anonymous self-administered questionnaire administer assess risk factor HPV . For IBD patient , information regard IBD diagnosis treatment obtain . An anal pap smear perform time clinic visit time already schedule colonoscopy . Samples collect processed Stanford pathology blind pathologist read specimen . Human Papillomavirus ( HPV ) DNA test perform specimen . All patient anal squamous intraepithelial lesion ( ASIL ) refer colorectal surgeon recommendation treatment , include high-resolution anoscopy .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>All IBD patient follow IBD clinic healthy control great 18 year old History HPV vaccination Pregnancy Other immunosuppressed state ( i.e . systemic lupus erythematosus , rheumatoid arthritis , cancer , Human Immunodeficiency Virus ( HIV ) , transplant ) IBD patient n't meet immunosuppression/nonimmunosuppression criterion Inability obtain informed consent patient Previous diagnosis ASIL anal/rectal cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>ASIL</keyword>
	<keyword>Anal dysplasia</keyword>
	<keyword>IBD</keyword>
	<keyword>HPV DNA</keyword>
</DOC>